These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
423 related articles for article (PubMed ID: 18223199)
1. Targeted delivery of an Mecp2 transgene to forebrain neurons improves the behavior of female Mecp2-deficient mice. Jugloff DG; Vandamme K; Logan R; Visanji NP; Brotchie JM; Eubanks JH Hum Mol Genet; 2008 May; 17(10):1386-96. PubMed ID: 18223199 [TBL] [Abstract][Full Text] [Related]
2. Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis. Alvarez-Saavedra M; Sáez MA; Kang D; Zoghbi HY; Young JI Hum Mol Genet; 2007 Oct; 16(19):2315-25. PubMed ID: 17635839 [TBL] [Abstract][Full Text] [Related]
3. Postnatal changes in serotonergic innervation to the hippocampus of methyl-CpG-binding protein 2-null mice. Isoda K; Morimoto M; Matsui F; Hasegawa T; Tozawa T; Morioka S; Chiyonobu T; Nishimura A; Yoshimoto K; Hosoi H Neuroscience; 2010 Feb; 165(4):1254-60. PubMed ID: 19932741 [TBL] [Abstract][Full Text] [Related]
4. Postnatal loss of methyl-CpG binding protein 2 in the forebrain is sufficient to mediate behavioral aspects of Rett syndrome in mice. Gemelli T; Berton O; Nelson ED; Perrotti LI; Jaenisch R; Monteggia LM Biol Psychiatry; 2006 Mar; 59(5):468-76. PubMed ID: 16199017 [TBL] [Abstract][Full Text] [Related]
5. Environmental enrichment ameliorates a motor coordination deficit in a mouse model of Rett syndrome--Mecp2 gene dosage effects and BDNF expression. Kondo M; Gray LJ; Pelka GJ; Christodoulou J; Tam PP; Hannan AJ Eur J Neurosci; 2008 Jun; 27(12):3342-50. PubMed ID: 18557922 [TBL] [Abstract][Full Text] [Related]
6. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains. Itoh M; Ide S; Takashima S; Kudo S; Nomura Y; Segawa M; Kubota T; Mori H; Tanaka S; Horie H; Tanabe Y; Goto Y J Neuropathol Exp Neurol; 2007 Feb; 66(2):117-23. PubMed ID: 17278996 [TBL] [Abstract][Full Text] [Related]
7. Selective preservation of MeCP2 in catecholaminergic cells is sufficient to improve the behavioral phenotype of male and female Mecp2-deficient mice. Lang M; Wither RG; Brotchie JM; Wu C; Zhang L; Eubanks JH Hum Mol Genet; 2013 Jan; 22(2):358-71. PubMed ID: 23077217 [TBL] [Abstract][Full Text] [Related]
8. A segment of the Mecp2 promoter is sufficient to drive expression in neurons. Adachi M; Keefer EW; Jones FS Hum Mol Genet; 2005 Dec; 14(23):3709-22. PubMed ID: 16251199 [TBL] [Abstract][Full Text] [Related]
9. Behavioral and anatomical abnormalities in Mecp2 mutant mice: a model for Rett syndrome. Stearns NA; Schaevitz LR; Bowling H; Nag N; Berger UV; Berger-Sweeney J Neuroscience; 2007 May; 146(3):907-21. PubMed ID: 17383101 [TBL] [Abstract][Full Text] [Related]
10. Defective body-weight regulation, motor control and abnormal social interactions in Mecp2 hypomorphic mice. Kerr B; Alvarez-Saavedra M; Sáez MA; Saona A; Young JI Hum Mol Genet; 2008 Jun; 17(12):1707-17. PubMed ID: 18321865 [TBL] [Abstract][Full Text] [Related]
11. A methyl-CpG-binding protein 2-enhanced green fluorescent protein reporter mouse model provides a new tool for studying the neuronal basis of Rett syndrome. Schmid RS; Tsujimoto N; Qu Q; Lei H; Li E; Chen T; Blaustein CS Neuroreport; 2008 Mar; 19(4):393-8. PubMed ID: 18287934 [TBL] [Abstract][Full Text] [Related]
12. MeCP2 in neurons: closing in on the causes of Rett syndrome. Caballero IM; Hendrich B Hum Mol Genet; 2005 Apr; 14 Spec No 1():R19-26. PubMed ID: 15809268 [TBL] [Abstract][Full Text] [Related]
13. Evidence for both neuronal cell autonomous and nonautonomous effects of methyl-CpG-binding protein 2 in the cerebral cortex of female mice with Mecp2 mutation. Belichenko NP; Belichenko PV; Mobley WC Neurobiol Dis; 2009 Apr; 34(1):71-7. PubMed ID: 19167498 [TBL] [Abstract][Full Text] [Related]
14. Mecp2 deficiency is associated with learning and cognitive deficits and altered gene activity in the hippocampal region of mice. Pelka GJ; Watson CM; Radziewic T; Hayward M; Lahooti H; Christodoulou J; Tam PP Brain; 2006 Apr; 129(Pt 4):887-98. PubMed ID: 16467389 [TBL] [Abstract][Full Text] [Related]
16. Effects of postnatal dietary choline supplementation on motor regional brain volume and growth factor expression in a mouse model of Rett syndrome. Nag N; Mellott TJ; Berger-Sweeney JE Brain Res; 2008 Oct; 1237():101-9. PubMed ID: 18778693 [TBL] [Abstract][Full Text] [Related]
17. Treatment with desipramine improves breathing and survival in a mouse model for Rett syndrome. Roux JC; Dura E; Moncla A; Mancini J; Villard L Eur J Neurosci; 2007 Apr; 25(7):1915-22. PubMed ID: 17439480 [TBL] [Abstract][Full Text] [Related]
18. MeCP2 dysfunction in Rett syndrome and related disorders. Moretti P; Zoghbi HY Curr Opin Genet Dev; 2006 Jun; 16(3):276-81. PubMed ID: 16647848 [TBL] [Abstract][Full Text] [Related]
19. Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome. Asaka Y; Jugloff DG; Zhang L; Eubanks JH; Fitzsimonds RM Neurobiol Dis; 2006 Jan; 21(1):217-27. PubMed ID: 16087343 [TBL] [Abstract][Full Text] [Related]
20. Widespread changes in dendritic and axonal morphology in Mecp2-mutant mouse models of Rett syndrome: evidence for disruption of neuronal networks. Belichenko PV; Wright EE; Belichenko NP; Masliah E; Li HH; Mobley WC; Francke U J Comp Neurol; 2009 May; 514(3):240-58. PubMed ID: 19296534 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]